
TSE:NTR
This summary was created by AI, based on 23 opinions in the last 12 months.
Nutrien Ltd. (NTR-T) is seen as a promising investment opportunity by various experts despite recent market fluctuations and geopolitical tensions, particularly related to the Iran war impacting fertilizer components. Many reviews suggest the stock has shown signs of recovering from past downtrends, indicating a potential turnaround. Several experts highlight the importance of its stable dividend and robust retail operations, which provide a cushion against market volatility. While concerns surrounding fluctuating fertilizer prices remain prevalent, there is an overall sentiment that Nutrien is well-positioned for long-term growth, particularly as farmer balance sheets begin to improve and global agricultural demands rise. The consensus leans towards the stock being a solid buy for patient investors looking for long-term gains in the agriculture sector.
The most cyclical stock he owns. Crop prices have been all over the place. Harvest has been spotty. Tailwinds include continued geopolitical conflict between Russia-Ukraine, cheaper nat gas in NA. Demand will eventually return. Add at a reasonable price, sit and wait, and be patient.
NTR is now trading at 11.2x times' Forward P/E. In the 3Q, NTR’s revenue declined by -31% to $5.37B, missing estimates of $5.74B and EPS was $0.35 missing estimates of $0.65. The balance sheet has a net debt of $14.4B and a net debt/EBITDA is currently at 2.1x, okay for a cyclical name. NTR continues to return capital to shareholders through buybacks and dividends. The result was not strong, but given the strong market recently, it does help the share price to stabilize. Also, the expectations have gone down significantly, and comparison periods will get easier going forward. P/E is attractive at 11X.
Unlock Premium - Try 5i Free
Has been buying share recently. Demand for commodities not going away. Excellent capital allocation in management team. Current price is a good buying opportunity for long term investors.